Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Ves Dimov"'
Publikováno v:
Clinical and Translational Allergy, Vol 11, Iss 7, Pp n/a-n/a (2021)
Abstract Portable devices, such as smartphones and mobile Internet access have become ubiquitous in the last decades. The term ‘eHealth’ stands for electronic health. The tools included in the eHealth concept utilize phones, computers and the Int
Externí odkaz:
https://doaj.org/article/e5423f6459fc48cdac0a7eaabf9df83b
Autor:
Pavel Kolkhir, Dmitry Pogorelov, Razvigor Darlenski, Marco Caminati, Luciana Kase Tanno, Duy Le Pham, Alexei Gonzalez-Estrada, Darío Antolín-Amérigo, Ves Dimov, Karsten Weller, Mario Sánchez-Borges, Ignacio Ansotegui, Marcus Maurer, on behalf of the WAO Junior Members Group
Publikováno v:
World Allergy Organization Journal, Vol 11, Iss 1, Pp 1-13 (2018)
Abstract Background The approaches to the diagnosis and treatment of chronic spontaneous urticaria (CSU) differ in various parts of the world. We sought to determine the adherence to international and national urticaria guidelines as well as the moti
Externí odkaz:
https://doaj.org/article/a07c3daf4b32427f917285a710e0cd7f
Autor:
Raúl Lázaro Castro Almarales, Mary Carmen Reyes Zamora, Beatriz Tamargo, Damaris Torralba Averoff, Raysa Cruz, Yunia Oliva Diaz, Mirta Alvarez Castello, Alexander Ciria, Alexis Labrada, Maytee Mateo, Omar Herrera, José Severino Rodríguez Canosa, Biocen, Yamilet Ibizate Novales, Ilonka Estruch Fajardo, Armando Ginard, Bruce Lanser, Anna Faino, Erwin Gelfand, Pia Hauk, Silvia Venero Fernández, Julia Urbina, Ramón Suárez Medina, Hermes Fundora Hernández, John Britton, Andrew William Fogarty, Nabarun Ghosh, Clinton Ross Bell, Chandini Revanna, Constantine Saadeh, Jeff Bennert, Danius Bouyi, Mitsy Veloz, Nelofar Sherali, Magna Coelho, Joseph J. Dolence, Takao Kobayashi, Koji Iijima, Hirohito Kita, Ashli Moore, James Krempski, Roberta Aina, Riccardo Asero, Sabine Pfeifer, Pawel Dubiela, Merima Bublin, Christian Radauer, Piotr Humeniuk, Karin Hoffmann-Sommergruber, Frank Eidelman, Ves Dimov, Charl Khalil, Alice E. W. Hoyt, Peter Heymann, Alexander Schuyler, Scott Commins, Thomas Platts-Mills, Patrice Kruszewski, John Russo, Lisa Workman, Elizabeth Erwin, Anubha Tripathi, Gabriela Yvette Castellanos, Elizabeth Mendieta, Martín Becerril-Angeles
Publikováno v:
World Allergy Organization Journal, Vol 9, Iss S2, Pp 207-212 (2016)
Table of contents A1 Characterization of the immunoallergic profile towards the proteins of the wheat flour in Cuban population Raúl Lázaro Castro Almarales, Mary Carmen Reyes Zamora, Beatriz Tamargo, Damaris Torralba Averoff, Raysa Cruz, Yunia Oli
Externí odkaz:
https://doaj.org/article/62b5ff842f094a1589b88a50a1976ce1
Autor:
Smita Joshi, Ves Dimov
Publikováno v:
World Allergy Organization Journal, Vol 7, Iss , Pp - (2014)
Technology and social media have dramatically altered the landscape in which we practice medicine. Clinicians have increasingly turned to technology and the internet to enhance patient care. Allergists have used these modalities to improve utilizatio
Externí odkaz:
https://doaj.org/article/7522e0947e804e1eb1f96e7a6392f855
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB166
Publikováno v:
Current Opinion in Allergy & Clinical Immunology. 19:432-438
Anaphylaxis is a systemic allergic reaction and without the appropriate treatment can progress fast and may be fatal. Information about allergy and immunology topics including anaphylaxis can be easily found online and are widely searched by patients
Publikováno v:
Clinical and Translational Allergy, Vol 11, Iss 7, Pp n/a-n/a (2021)
Clinical and Translational Allergy
Clinical and Translational Allergy
Portable devices, such as smartphones and mobile Internet access have become ubiquitous in the last decades. The term ‘eHealth’ stands for electronic health. The tools included in the eHealth concept utilize phones, computers and the Internet and
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:1727-1730
Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the Food and Drug Administration (FDA) for the treatment of allergic conjunctivitis. In other countries, the oral p
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:S101
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 13:1275-1280
Mepolizumab is a humanized monoclonal antibody that binds to and inactivates IL-5. It is available as a subcutaneous preparation. The practical application of mepolizumab is as an add-on therapy in the treatment of severe eosinophilic asthma. Areas c